Australia Uses AI to Speed Medicine Approvals by 50 Days

Red tape is getting a high-tech makeover in Australia, and it could mean faster access to life-saving medicines for millions of people.

The Australian government announced plans to use artificial intelligence to help speed up drug approvals and housing permits, part of a $10.2 billion push to modernize regulatory processes. The best part? Humans still make the final call on every decision.

Here's how it works for medicines. Australia's Therapeutic Goods Administration already looks at approvals from other countries as a shortcut for drug safety reviews. Now, AI will compare international regulations and flag which medicines meet Australian standards, saving manufacturers $340 million annually and getting treatments to patients faster.

The key detail that might ease concerns: AI handles the paperwork, not the decisions. Human experts at the TGA still review everything and make the final determination about whether a medicine is safe for Australians.

This isn't just a theory. The UK tested a similar system in 2025 and saw clinical trial approval times plummet from 91 days to just 41 days. The structure was identical: AI assists, humans decide.

Housing developers will also get help navigating complex environmental approval processes. The government is building an AI tool to guide them through documentation and requirements, aiming for what one minister called "faster yeses and faster noes."

A spokesperson confirmed that assessment officers, not AI, will always make approval decisions. The technology just helps people find their way through complicated laws and paperwork.

The Ripple Effect

Beyond medicine and housing, AI is popping up across government services in surprisingly helpful ways. The National Library of Australia is using it to transcribe 58,000 hours of oral history recordings, preserving voices and stories that might otherwise remain locked away. Small businesses can now chat with an AI tool for quick answers about intellectual property questions.

Queensland University of Technology law professor Nic Suzor, who studies government information access, sees real promise here. He calls this use of AI "inevitable and mostly good," especially for connecting scattered data across departments.

The approach addresses a massive pain point: information trapped in silos across government agencies. Current AI excels at exactly this kind of integration work, making knowledge accessible that was previously buried in filing systems.

Experts emphasize the importance of details and safeguards. Privacy protections and bias checks matter, especially when AI helps shape what information gets highlighted in any approval process.

The government's strategy seems clear: use AI where it shines at organizing and presenting information, but keep human judgment at the heart of decisions that affect people's health, homes, and lives.

Faster approvals could mean patients access breakthrough treatments months earlier, and families move into new homes sooner.